Cabergoline for preventing ovarian hyperstimulation syndrome
Huilin Tang, Tamara Hunter, HU Yong-fang, Suo-Di Zhai, Xiaoyan Sheng, Roger J Hart
Abstract
Huilin Tang, Tamara Hunter, HU Yong-fang, Suo-Di Zhai, Xiaoyan Sheng, Roger J Hart
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of cabergoline in preventing ovarian hyperstimulation syndrome (OHSS) in high‐risk patients undergoing assisted reproduction technology treatment.
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of cabergoline in preventing ovarian hyperstimulation syndrome (OHSS) in high‐risk patients undergoing assisted reproduction technology treatment.
Key concepts: Cabergoline, Ovarian hyperstimulation syndrome, Medicine, Gynecology, Internal medicine, Biology, Pregnancy, In vitro fertilisation